Replimune Group Cash from Financing (Quarterly) Trends

Replimune Group Inc (REPL)

10.80 -0.60 (-5.26%) USD | NASDAQ | Nov 15, 16:00

10.80 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
September 30, 2024	-0.039M
June 30, 2024	96.64M
March 31, 2024	-0.13M
December 31, 2023	14.87M
September 30, 2023	0.438M
June 30, 2023	1.105M
March 31, 2023	-0.077M
December 31, 2022	271.44M
September 30, 2022	7.423M
June 30, 2022	32.52M
March 31, 2022	0.359M
December 31, 2021	3.969M
September 30, 2021	1.15M
June 30, 2021	1.12M
March 31, 2021	0.785M

Date	Value
December 31, 2020	262.20M
September 30, 2020	-0.035M
June 30, 2020	109.51M
March 31, 2020	0.034M
December 31, 2019	90.36M
September 30, 2019	9.75M
June 30, 2019	0.018M
March 31, 2019	0.041M
December 31, 2018	0.153M
September 30, 2018	101.39M
June 30, 2018	-0.195M
March 31, 2018	0.00
December 31, 2017	0.00
September 30, 2017	54.75M
June 30, 2017	0.00

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

-0.13M

Minimum

Mar 2024

271.44M

Maximum

Dec 2022

44.68M

Average

1.135M

Median

Cash from Financing (Quarterly) Benchmarks

Bristol-Myers Squibb Co	-3.852B
Nuvalent Inc	550.27M
NovaBay Pharmaceuticals Inc	2.089M
Palatin Technologies Inc	5.991M
iBio Inc	12.99M

Cash from Financing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-38.64M
Cash from Investing (Quarterly)	0.458M
Free Cash Flow	-188.31M
Free Cash Flow Per Share (Quarterly)	-0.5183
Free Cash Flow Yield	-24.81%